rs766667249
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PM4_SupportingPP5_Very_Strong
The NM_004204.5(PIGQ):c.1199_1201delACT(p.Tyr400del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000207 in 1,612,690 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00022 ( 0 hom. )
Consequence
PIGQ
NM_004204.5 disruptive_inframe_deletion
NM_004204.5 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.47
Genes affected
PIGQ (HGNC:14135): (phosphatidylinositol glycan anchor biosynthesis class Q) This gene is involved in the first step in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes a N-acetylglucosaminyl transferase component that is part of the complex that catalyzes transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_004204.5. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 16-578911-TCTA-T is Pathogenic according to our data. Variant chr16-578911-TCTA-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 449630.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151672Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
17
AN:
151672
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000152 AC: 38AN: 250380Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135620
GnomAD3 exomes
AF:
AC:
38
AN:
250380
Hom.:
AF XY:
AC XY:
19
AN XY:
135620
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000218 AC: 318AN: 1460902Hom.: 0 AF XY: 0.000215 AC XY: 156AN XY: 726798
GnomAD4 exome
AF:
AC:
318
AN:
1460902
Hom.:
AF XY:
AC XY:
156
AN XY:
726798
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000105 AC: 16AN: 151788Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74126
GnomAD4 genome
AF:
AC:
16
AN:
151788
Hom.:
Cov.:
33
AF XY:
AC XY:
8
AN XY:
74126
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | PIGQ: PM3:Very Strong, PM2, PM4, PS3:Supporting - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 12, 2024 | In-frame deletion of one amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27513193, 32588908, 31148362, 32746448, 37923198) - |
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 19, 2021 | The c.1199_1201delACT (p.Y400del) alteration is located in exon 6 (coding exon 5) of the PIGQ gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions 1199 and 1201, resulting in the deletion of a tyrosine (Y) at amino acid position 400. Based on data from the Genome Aggregation Database (gnomAD) database, the PIGQ c.1199_1201delACT alteration was observed in 0.014% (40/281,686) of total alleles studied, with a frequency of 0.03% (37/128,562) in the European (non-Finnish) subpopulation. The p.Y400del alteration has been reported in trans with a second PIGQ alteration in multiple patients with infantile epileptic encephalopathy (Johnstone, 2020). The p.Y400 amino acid is conserved in available vertebrate species. The p.Y400 amino acid is located in the third transmembrane region of the PIGQ catalytic domain. The p.Y400del alteration is predicted to be deleterious with a score of -16.01 by PROVEAN in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. - |
Epilepsy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | This variant, c.1199_1201del, results in the deletion of 1 amino acid(s) of the PIGQ protein (p.Tyr400del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs766667249, gnomAD 0.03%). This variant has been observed in individual(s) with PIGQ-related conditions (PMID: 31148362, 32588908). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 449630). For these reasons, this variant has been classified as Pathogenic. - |
Developmental and epileptic encephalopathy, 77 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 26, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at